Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ajinomoto Co Inc's Wholly Owned Subsidiary to Establish New Joint Venture with Yoshindo Inc.


Monday, 24 Dec 2012 11:30pm EST 

Ajinomoto Co Inc announced that its wholly owned subsidiary, Ajinomoto Pharmaceuticals Co., Ltd., will establish a new joint venture, which will be engaged in the manufacturing and sales of transfusion and dialysis related medical supplies in Tokyo, Japan, with Yoshindo Inc., effective July 1, 2013. The new joint venture will be capitalized at JPY 100 million. Ajinomoto Pharmaceuticals and Yoshindo Inc. will hold 49% and 51% stakes in the joint venture, respectively. 

Company Quote

1594.5
-29.0 -1.79%
2:00am EDT